AMAG Pharmaceuticals, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

  AMAG Pharmaceuticals, Inc. to Present at the Lazard Capital Markets 9th
  Annual Healthcare Conference

Lazard Capital Markets 9th Annual Healthcare Conference

Business Wire

LEXINGTON, Mass. -- November 07, 2012

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that Frank Thomas,
AMAG’s Chief Operating Officer, will present a company overview and business
update at the Lazard Capital Markets 9^th Annual Healthcare Conference on
Tuesday, November 13, 2012 at 8:00 am ET in New York, NY.

A live webcast of the presentation will be accessible through the Investors
section of the company’s website at www.amagpharma.com. Following the
conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc.
website until December 13, 2012.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on
the development and commercialization of a therapeutic iron compound to treat
iron deficiency anemia. For additional company information, please visit
www.amagpharma.com.

Contact:

AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303
 
Press spacebar to pause and continue. Press esc to stop.